UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

MET Exon 14 Alterations in Lung Cancer: Exon Skipping Extends Half-Life

Clinical cancer research, 2016-06, Vol.22 (12), p.2832-2834

Drilon, Alexander

2016

Volltextzugriff (PDF)

NTRK fusion-positive cancers and TRK inhibitor therapy

Nature reviews. Clinical oncology, 2018-12, Vol.15 (12), p.731-747

2018

Volltextzugriff (PDF)

MET-dependent solid tumours - molecular diagnosis and targeted therapy

Nature reviews. Clinical oncology, 2020-09, Vol.17 (9), p.569-587

2020

Volltextzugriff (PDF)

State-of-the-Art Strategies for Targeting RET -Dependent Cancers

Journal of clinical oncology, 2020-04, Vol.38 (11), p.1209-1221

2020

Volltextzugriff (PDF)

ROS1-dependent cancers - biology, diagnostics and therapeutics

Nature reviews. Clinical oncology, 2021-01, Vol.18 (1), p.35-55

2021

Volltextzugriff (PDF)

Antitumor activity of crizotinib in lung cancers harboring a MET exon 14 alteration

Nature medicine, 2020-01, Vol.26 (1), p.47-51

2020

Volltextzugriff (PDF)

Optimizing the sequencing of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC)

Lung cancer (Amsterdam, Netherlands), 2019-11, Vol.137, p.113-122

2019

Volltextzugriff (PDF)

Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets

Clinical cancer research, 2016-07, Vol.22 (14), p.3618-3629

2016

Volltextzugriff (PDF)

RASA1 and NF1 are Preferentially Co-Mutated and Define A Distinct Genetic Subset of Smoking-Associated Non-Small Cell Lung Carcinomas Sensitive to MEK Inhibition

Clinical cancer research, 2018-03, Vol.24 (6), p.1436-1447

2018

Volltextzugriff (PDF)

Squamous-cell carcinomas of the lung: emerging biology, controversies, and the promise of targeted therapy

The lancet oncology, 2012-10, Vol.13 (10), p.e418-e426

2012

Volltextzugriff (PDF)

Targeted therapy outcomes in RET -rearranged lung cancers: drug or driver?

The lancet respiratory medicine, 2017-01, Vol.5 (1), p.5-6

Drilon, Alexander

2017

Volltextzugriff (PDF)

NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls

Modern pathology, 2020-01, Vol.33 (1), p.38-46

2020

Volltextzugriff (PDF)

Pan-Trk Immunohistochemistry Is an Efficient and Reliable Screen for the Detection of NTRK Fusions

The American journal of surgical pathology, 2017-11, Vol.41 (11), p.1547-1551

2017

Volltextzugriff (PDF)

The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers

Nature communications, 2022-03, Vol.13 (1), p.1450-1450, Article 1450

2022

Volltextzugriff (PDF)

Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes

Nature reviews. Clinical oncology, 2018-03, Vol.15 (3), p.151-167

2018

Volltextzugriff (PDF)

Expanding the Molecular Characterization of Thoracic Inflammatory Myofibroblastic Tumors beyond ALK Gene Rearrangements

Journal of thoracic oncology, 2019-05, Vol.14 (5), p.825-834

2019

Volltextzugriff (PDF)

Cabozantinib in patients with advanced RET -rearranged non-small-cell lung cancer: an open-label, single-centre, phase 2, single-arm trial

The lancet oncology, 2016-12, Vol.17 (12), p.1653-1660

2016

Volltextzugriff (PDF)

Organizing precision medicine: A case study of Memorial Sloan Kettering Cancer Center's engagement in/with genomics

Social science & medicine (1982), 2023-05, Vol.324, p.115789-115789, Article 115789

2023

Volltextzugriff (PDF)

MET IHC Is a Poor Screen for MET Amplification or MET Exon 14 Mutations in Lung Adenocarcinomas: Data from a Tri-Institutional Cohort of the Lung Cancer Mutation Consortium

Journal of thoracic oncology, 2019-09, Vol.14 (9), p.1666-1671

2019

Volltextzugriff (PDF)

Decision‐making as discovery: Vetting clinical research in a leading precision oncology service

Sociology of health & illness, 2024-03, Vol.46 (3), p.495-513

2024

Volltextzugriff (PDF)

Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA

Nature medicine, 2022-05, Vol.28 (5), p.946-957

2022

Volltextzugriff (PDF)

Colorectal Carcinomas Containing Hypermethylated MLH1 Promoter and Wild-Type BRAF/KRAS Are Enriched for Targetable Kinase Fusions

Cancer research (Chicago, Ill.), 2019-03, Vol.79 (6), p.1047-1053

2019

Volltextzugriff (PDF)

1 – 25 von 458

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(425)
Mit Volltextzugriff
(375)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(197)
Life Sciences & Biomedicine
(190)
Oncology
(173)
Humans
(155)
Mutation
(73)
Female
(68)
Lung Neoplasms - Drug Therapy
(64)
Lung Neoplasms - Genetics
(64)
Male
(61)
Middle Aged
(57)
Aged
(54)
Adult
(46)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(46)
Patients
(39)
Tumors
(39)
Lung Cancer
(38)
Aged, 80 And Over
(36)
Protein Kinase Inhibitors - Therapeutic Use
(34)
Neoplasms - Drug Therapy
(33)
Respiratory System
(32)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

MET Exon 14 Alterations in Lung Cancer: Exon Skipping Extends Half-Life

NTRK fusion-positive cancers and TRK inhibitor therapy

MET-dependent solid tumours - molecular diagnosis and targeted therapy

State-of-the-Art Strategies for Targeting RET -Dependent Cancers

ROS1-dependent cancers - biology, diagnostics and therapeutics

Antitumor activity of crizotinib in lung cancers harboring a MET exon 14 alteration

Optimizing the sequencing of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC)

Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets

RASA1 and NF1 are Preferentially Co-Mutated and Define A Distinct Genetic Subset of Smoking-Associated Non-Small Cell Lung Carcinomas Sensitive to MEK Inhibition

Squamous-cell carcinomas of the lung: emerging biology, controversies, and the promise of targeted therapy

Targeted therapy outcomes in RET -rearranged lung cancers: drug or driver?

NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls

Pan-Trk Immunohistochemistry Is an Efficient and Reliable Screen for the Detection of NTRK Fusions

The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers

Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes

Expanding the Molecular Characterization of Thoracic Inflammatory Myofibroblastic Tumors beyond ALK Gene Rearrangements

Cabozantinib in patients with advanced RET -rearranged non-small-cell lung cancer: an open-label, single-centre, phase 2, single-arm trial

Organizing precision medicine: A case study of Memorial Sloan Kettering Cancer Center's engagement in/with genomics

Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1)

MET IHC Is a Poor Screen for MET Amplification or MET Exon 14 Mutations in Lung Adenocarcinomas: Data from a Tri-Institutional Cohort of the Lung Cancer Mutation Consortium

RET Solvent Front Mutations Mediate Acquired Resistance to Selective RET Inhibition in RET-Driven Malignancies

Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms

Decision‐making as discovery: Vetting clinical research in a leading precision oncology service

Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA

Colorectal Carcinomas Containing Hypermethylated MLH1 Promoter and Wild-Type BRAF/KRAS Are Enriched for Targetable Kinase Fusions

Suchergebnisse filtern